<?xml version='1.0' encoding='utf-8'?>
<document id="23781659"><sentence text="Effect of esomeprazole on pharmacokinetics of phenytoin in rabbits."><entity charOffset="10-22" id="DDI-PubMed.23781659.s1.e0" text="esomeprazole" /><entity charOffset="46-55" id="DDI-PubMed.23781659.s1.e1" text="phenytoin" /><pair ddi="false" e1="DDI-PubMed.23781659.s1.e0" e2="DDI-PubMed.23781659.s1.e0" /><pair ddi="false" e1="DDI-PubMed.23781659.s1.e0" e2="DDI-PubMed.23781659.s1.e1" /></sentence><sentence text="Esomeprazole is commonly prescribed proton pump inhibitor for gastritis and peptic ulcer disease"><entity charOffset="0-12" id="DDI-PubMed.23781659.s2.e0" text="Esomeprazole" /></sentence><sentence text=" Most of the time in clinical practice, phenytoin and esomeprazole are prescribed for patients of generalized seizures with concomitant peptic ulcer"><entity charOffset="40-49" id="DDI-PubMed.23781659.s3.e0" text="phenytoin" /><entity charOffset="54-66" id="DDI-PubMed.23781659.s3.e1" text="esomeprazole" /><pair ddi="false" e1="DDI-PubMed.23781659.s3.e0" e2="DDI-PubMed.23781659.s3.e0" /><pair ddi="false" e1="DDI-PubMed.23781659.s3.e0" e2="DDI-PubMed.23781659.s3.e1" /></sentence><sentence text=" Hence there are chances of drug-drug interaction because of modulations of isoenzymes CYP2C9 and CYP2C19, are involved in metabolism of phenytoin and esomeprazole"><entity charOffset="137-146" id="DDI-PubMed.23781659.s4.e0" text="phenytoin" /><entity charOffset="151-163" id="DDI-PubMed.23781659.s4.e1" text="esomeprazole" /><pair ddi="false" e1="DDI-PubMed.23781659.s4.e0" e2="DDI-PubMed.23781659.s4.e0" /><pair ddi="false" e1="DDI-PubMed.23781659.s4.e0" e2="DDI-PubMed.23781659.s4.e1" /></sentence><sentence text=" But it is important to maintain the therapeutic level of phenytoin in plasma for effective seizures control"><entity charOffset="58-67" id="DDI-PubMed.23781659.s5.e0" text="phenytoin" /></sentence><sentence text=" So, the aim of the study was to determine the effect of esomeprazole on the pharmacokinetics of phenytoin in rabbits"><entity charOffset="57-69" id="DDI-PubMed.23781659.s6.e0" text="esomeprazole" /><entity charOffset="97-106" id="DDI-PubMed.23781659.s6.e1" text="phenytoin" /><pair ddi="false" e1="DDI-PubMed.23781659.s6.e0" e2="DDI-PubMed.23781659.s6.e0" /><pair ddi="false" e1="DDI-PubMed.23781659.s6.e0" e2="DDI-PubMed.23781659.s6.e1" /></sentence><sentence text=" In a parallel design study, phenytoin, 30 mg/kg/day per oral was given daily for 14 days"><entity charOffset="29-38" id="DDI-PubMed.23781659.s7.e0" text="phenytoin" /></sentence><sentence text=" On day 15, blood samples were taken at various time intervals between 0-24 hours" /><sentence text=" In esomeprazole-phenytoin group, phenytoin was administered for seven days as mentioned earlier and from day 8th onward, esomeprazole 2"><entity charOffset="4-16" id="DDI-PubMed.23781659.s9.e0" text="esomeprazole" /><entity charOffset="17-26" id="DDI-PubMed.23781659.s9.e1" text="phenytoin" /><entity charOffset="34-43" id="DDI-PubMed.23781659.s9.e2" text="phenytoin" /><entity charOffset="122-134" id="DDI-PubMed.23781659.s9.e3" text="esomeprazole" /><pair ddi="false" e1="DDI-PubMed.23781659.s9.e0" e2="DDI-PubMed.23781659.s9.e0" /><pair ddi="false" e1="DDI-PubMed.23781659.s9.e0" e2="DDI-PubMed.23781659.s9.e1" /><pair ddi="false" e1="DDI-PubMed.23781659.s9.e0" e2="DDI-PubMed.23781659.s9.e2" /><pair ddi="false" e1="DDI-PubMed.23781659.s9.e0" e2="DDI-PubMed.23781659.s9.e3" /><pair ddi="false" e1="DDI-PubMed.23781659.s9.e1" e2="DDI-PubMed.23781659.s9.e1" /><pair ddi="false" e1="DDI-PubMed.23781659.s9.e1" e2="DDI-PubMed.23781659.s9.e2" /><pair ddi="false" e1="DDI-PubMed.23781659.s9.e1" e2="DDI-PubMed.23781659.s9.e3" /><pair ddi="false" e1="DDI-PubMed.23781659.s9.e2" e2="DDI-PubMed.23781659.s9.e2" /><pair ddi="false" e1="DDI-PubMed.23781659.s9.e2" e2="DDI-PubMed.23781659.s9.e3" /></sentence><sentence text="8 mg/kg along with phenytoin 30 mg/kg/day was administered till 14th days and blood samples were drawn as above on 15th day"><entity charOffset="19-28" id="DDI-PubMed.23781659.s10.e0" text="phenytoin" /></sentence><sentence text=" Plasma phenytoin levels were assayed by HPLC and pharmacokinetic parameters were calculated" /><sentence text=" In esomeprazole-phenytoin group, there was a significant increase of t1/2el than phenytoin alone group and significant increase in AUC0-24 was also observed in the esomeprazole and phenytoin treated group"><entity charOffset="4-16" id="DDI-PubMed.23781659.s12.e0" text="esomeprazole" /><entity charOffset="17-26" id="DDI-PubMed.23781659.s12.e1" text="phenytoin" /><entity charOffset="82-91" id="DDI-PubMed.23781659.s12.e2" text="phenytoin" /><entity charOffset="165-177" id="DDI-PubMed.23781659.s12.e3" text="esomeprazole" /><entity charOffset="182-191" id="DDI-PubMed.23781659.s12.e4" text="phenytoin" /><pair ddi="false" e1="DDI-PubMed.23781659.s12.e0" e2="DDI-PubMed.23781659.s12.e0" /><pair ddi="false" e1="DDI-PubMed.23781659.s12.e0" e2="DDI-PubMed.23781659.s12.e1" /><pair ddi="false" e1="DDI-PubMed.23781659.s12.e0" e2="DDI-PubMed.23781659.s12.e2" /><pair ddi="false" e1="DDI-PubMed.23781659.s12.e0" e2="DDI-PubMed.23781659.s12.e3" /><pair ddi="false" e1="DDI-PubMed.23781659.s12.e0" e2="DDI-PubMed.23781659.s12.e4" /><pair ddi="false" e1="DDI-PubMed.23781659.s12.e1" e2="DDI-PubMed.23781659.s12.e1" /><pair ddi="false" e1="DDI-PubMed.23781659.s12.e1" e2="DDI-PubMed.23781659.s12.e2" /><pair ddi="false" e1="DDI-PubMed.23781659.s12.e1" e2="DDI-PubMed.23781659.s12.e3" /><pair ddi="false" e1="DDI-PubMed.23781659.s12.e1" e2="DDI-PubMed.23781659.s12.e4" /><pair ddi="false" e1="DDI-PubMed.23781659.s12.e2" e2="DDI-PubMed.23781659.s12.e2" /><pair ddi="false" e1="DDI-PubMed.23781659.s12.e2" e2="DDI-PubMed.23781659.s12.e3" /><pair ddi="false" e1="DDI-PubMed.23781659.s12.e2" e2="DDI-PubMed.23781659.s12.e4" /><pair ddi="false" e1="DDI-PubMed.23781659.s12.e3" e2="DDI-PubMed.23781659.s12.e3" /><pair ddi="false" e1="DDI-PubMed.23781659.s12.e3" e2="DDI-PubMed.23781659.s12.e4" /></sentence><sentence text=" These results suggest that esomeprazole alters the pharmacokinetics of phenytoin"><entity charOffset="28-40" id="DDI-PubMed.23781659.s13.e0" text="esomeprazole" /><entity charOffset="72-81" id="DDI-PubMed.23781659.s13.e1" text="phenytoin" /><pair ddi="false" e1="DDI-PubMed.23781659.s13.e0" e2="DDI-PubMed.23781659.s13.e0" /><pair ddi="false" e1="DDI-PubMed.23781659.s13.e0" e2="DDI-PubMed.23781659.s13.e1" /></sentence><sentence text=" Confirmation of these results in further clinical studies will warrant changes in phenytoin dose or frequency when esomeprazole is co-administered"><entity charOffset="116-128" id="DDI-PubMed.23781659.s14.e0" text="esomeprazole" /></sentence><sentence text="" /></document>